Myocardial infarction (MI) belongs to the family of cardiovascular diseases and represents the primary cause of worldwide mortality. Despite the promising results achieved in both small and large animal studies, recent meta-analyses highlighted the marginal effect of therapeutic strategies like bone-marrow derived stem cells once they are tested in the clinical trials. Mammalian adult cardiomyocytes are able to re-enter the cell-cycle only during the first week after birth, thus avoiding the maladaptive remodelling which characterises post-ischemic phases in the adult. In this thesis a study included the identification of significant differences in the cellular membrane glycosylation from tissue samples harvested from neonatal and adult rat...
Injectable decellularized matrix hydrogels derived from either myocardium or small intestinal submuc...
Injectable scaffolds for cardiac tissue regeneration are a promising therapeutic approach for progre...
Adipose derived stromal cells (ADSC) are relevant therapeutic agents to treat myocardial infarction ...
Myocardial infarction (MI) belongs to the family of cardiovascular diseases and represents the prima...
Cardiovascular disease is the leading cause of death in the United States and the rest of the wester...
With improved management of patients with acute myocardial infarctions (MI), the prevalence in heart...
Myocardial infarction is the first cause of worldwide mortality, with an increasing incidence also r...
This thesis employed a stem cell encapsulating hydrogel patch to increase the amount of beneficial s...
Human epicardium-derived cells (hEPDCs) transplanted in the NOD-SCID mouse heart after myocardial in...
Cardiovascular diseases (CVD) are the leading cause of death worldwide. Among them, myocardial infar...
International audienceBACKGROUND: To improve the efficacy of bone marrow-derived mesenchymal stem ce...
Human epicardium-derived cells (hEPDCs) transplanted in the NOD-SCID mouse heart after myocardial in...
Tissue engineering offers an exciting possibility for cardiac repair post myocardial infarction. We ...
BACKGROUND: Mesenchymal stromal cells (MSC) repair infarcted hearts mainly through paracrine mechan...
A first-in-man clinical study on a myocardial-derived decellularized extracellular matrix hydrogel s...
Injectable decellularized matrix hydrogels derived from either myocardium or small intestinal submuc...
Injectable scaffolds for cardiac tissue regeneration are a promising therapeutic approach for progre...
Adipose derived stromal cells (ADSC) are relevant therapeutic agents to treat myocardial infarction ...
Myocardial infarction (MI) belongs to the family of cardiovascular diseases and represents the prima...
Cardiovascular disease is the leading cause of death in the United States and the rest of the wester...
With improved management of patients with acute myocardial infarctions (MI), the prevalence in heart...
Myocardial infarction is the first cause of worldwide mortality, with an increasing incidence also r...
This thesis employed a stem cell encapsulating hydrogel patch to increase the amount of beneficial s...
Human epicardium-derived cells (hEPDCs) transplanted in the NOD-SCID mouse heart after myocardial in...
Cardiovascular diseases (CVD) are the leading cause of death worldwide. Among them, myocardial infar...
International audienceBACKGROUND: To improve the efficacy of bone marrow-derived mesenchymal stem ce...
Human epicardium-derived cells (hEPDCs) transplanted in the NOD-SCID mouse heart after myocardial in...
Tissue engineering offers an exciting possibility for cardiac repair post myocardial infarction. We ...
BACKGROUND: Mesenchymal stromal cells (MSC) repair infarcted hearts mainly through paracrine mechan...
A first-in-man clinical study on a myocardial-derived decellularized extracellular matrix hydrogel s...
Injectable decellularized matrix hydrogels derived from either myocardium or small intestinal submuc...
Injectable scaffolds for cardiac tissue regeneration are a promising therapeutic approach for progre...
Adipose derived stromal cells (ADSC) are relevant therapeutic agents to treat myocardial infarction ...